N4 Pharma ( (GB:N4P) ) has provided an update.
N4 Pharma PLC has announced a change in its voting rights structure, with the percentage of voting rights attached to shares decreasing from 4.30% to 2.04%. This change follows an increase in the company’s issued share capital due to a recent Placing announced on June 7. The adjustment in voting rights may impact stakeholder influence and company governance, reflecting the company’s evolving capital structure.
More about N4 Pharma
N4 Pharma PLC operates in the pharmaceutical industry, focusing on the development of novel drug delivery systems. The company is primarily engaged in creating innovative solutions to enhance the delivery and efficacy of existing drugs, with a market focus on improving therapeutic outcomes.
YTD Price Performance: -27.88%
Average Trading Volume: 2,104,244
Technical Sentiment Signal: Buy
Current Market Cap: £4.61M
Find detailed analytics on N4P stock on TipRanks’ Stock Analysis page.